Clinical trial
VEAPS: Vitamin E Atherosclerosis Prevention Study
NCT00114387 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00114387 |
|---|---|
| Title | VEAPS: Vitamin E Atherosclerosis Prevention Study |
| Official title | VEAPS: Vitamin E Atherosclerosis Prevention Study |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis |
| Intervention type | Drug |
| Interventions | DL-alpha-tocopherol |
| Enrollment | 353 |
| Start date | Jul 1, 1996 |
| Primary completion | Sep 1, 2000 |
| Completion | Sep 1, 2000 |
| First posted | Jun 15, 2005 |
| Last update posted | Dec 11, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: